COST-EFFECTIVENESS OF A SINGLE-INHALER TRIPLE THERAPY VS A DUAL BRONCHODILATOR FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN AUSTRALIA

被引：0

作者：

Schembri, S. ^{[1
]}

Schroeder, M. ^{[2
]}

Shah, D. ^{[3
]}

Martin, A. ^{[4
]}

Ndirangu, A. ^{[3
]}

Risebrough, N. ^{[3
]}

Thrasis, A. ^{[5
]}

Bremner, P. ^{[6
]}

Haberl, M. ^{[5
]}

Ismaila, A. ^{[7
]}

机构：

[1] Canberra Hosp, Dept Resp & Sleep Med, Garran, ACT, Australia

[2] GlaxoSmithKline, Value Evidence & Outcomes, Brentford, England

[3] ICON Hlth Econ, Dublin, Ireland

[4] GlaxoSmithKline, Value Evidence Analyt, Brentford, England

[5] GlaxoSmithKline, Reimbursement & Pricing, Brentford, England

[6] Univ Notre Dame, Sch Med, Resp Med, Notre Dame, IN 46556 USA

[7] GlaxoSmithKline, Value Evidence & Outcomes, Brentford, England

来源：

RESPIROLOGY | 2020年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

TP 071

引用

页码：145 / 145

页数：1

共 50 条

[1] COST-EFFECTIVENESS OF A SINGLE-INHALER TRIPLE THERAPY VS A DUAL BRONCHODILATOR FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN AUSTRALIA
Schembri, S.
Schroeder, M.
Shah, D.
Martin, A.
Ndirangu, K.
Risebrough, N.
Thrasis, A.
Bremner, P.
Haberl, M.
Ismaila, A.
RESPIROLOGY, 2021, 26 : 119 - 119
[2] Cost-effectiveness of a Single-Inhaler Triple Therapy Versus a Dual Bronchodilator for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Australia
Schroeder, M.
Shah, D.
Martin, A.
Ndirangu, K.
Risebrough, N.
Thrasis, A.
Schembri, S.
Bremner, P.
Haberl, M.
Ismaila, A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[3] THE IMPACT TRIAL: COST-EFFECTIVENESS ANALYSIS OF SINGLE-INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS DUAL BRONCHODILATOR THERAPY (UMEC/VI) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN
Vallejo-Aparicio, L. A.
Paly, V. F.
Schroeder, M.
Martin, A.
Risebrough, N.
Abreu, C.
Biswas, C.
Izquierdo Alonso, J. L.
Riesco Miranda, J. A.
Soler Cataluna, J. J.
Ismaila, A. S.
VALUE IN HEALTH, 2019, 22 : S878 - S878
[4] A SYSTEMATIC REVIEW OF SINGLE-INHALER TRIPLE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Langham, S.
Lewis, J.
Pooley, N.
Embleton, N.
Langham, J.
VALUE IN HEALTH, 2019, 22 : S873 - S873
[5] Single-inhaler triple vs single-inhaler dual therapy in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized control trials
Long, Huanyu
Xu, Hongxuan
Janssens, Jean-Paul
Guo, Yanfei
RESPIRATORY RESEARCH, 2021, 22 (01)
[6] Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK
Fenwick, Elisabeth
Martin, Alan
Schroeder, Melanie
Mealing, Stuart J.
Solanke, Oyinkansola
Risebrough, Nancy
Ismaila, Afisi S.
ERJ OPEN RESEARCH, 2021, 7 (01)
[7] Single-inhaler triple vs single-inhaler dual therapy in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized control trials
Huanyu Long
Hongxuan Xu
Jean-Paul Janssens
Yanfei Guo
Respiratory Research, 22
[8] Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective
Schroeder, Melanie
Benjamin, Nicole
Atienza, Laura
Biswas, Chandroday
Martin, Alan
Whalen, John D.
Izquierdo Alonso, Jose Luis
Riesco Miranda, Juan Antonio
Jose Soler-Cataluna, Juan
Huerta, Alicia
Ismaila, Afisi S.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 1621 - 1632
[9] Cost-effectiveness of single-inhaler triple therapy for patients with severe COPD: a systematic literature review
Rana, Rezwanul Hasan
Alam, Khorshed
Keramat, Syed Afroz
Gow, Jeff
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2022, 16 (10) : 1067 - 1084
[10] Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review
Langham, Sue
Lewis, Jen
Pooley, Nick
Embleton, Nina
Langham, Julia
Han, MeiLan K.
Chalmers, James D.
RESPIRATORY RESEARCH, 2019, 20 (01)

← 1 2 3 4 5 →